Implementing SAMHSA’s Final Rule: Challenges and Outcomes for Opioid Treatment Programs

Friday, April 25, 2025

10:30 AM – 11:45 AM

Presenter(s)

Robert C. Sherrick, MD, DFASAM

Chief Science Officer
Community Medical Services
Kalispell, Montana
Hillary Tamar, MD, FASAM

Eastern Territory Medical Director
Community Medical Services
Milwaukee , Wisconsin
Mark Schaefer, EDS, MA

Executive Vice President of Clinical Services
Community Medical Services
Scottsdale, Arizona

This session will explore the challenges and outcomes associated with implementing the Final Rule across 60 OTPs in 12 states. We will present data comparing states that have adopted the new policies with those that have not, offering insight into the operational and clinical impact. Attendees will gain practical strategies for navigating regulatory changes and enhancing patient outcomes in their OTPs.

Learning Objectives:

Learners will be able to:

Understand the history of SAMHSA regulations of Opioid Treatment Programs and the changes that were included in the Final Rule, published in April 2024.
How to interpret the Final Rule changes and create policies and procedures for medical providers, nurses, and counselors working in Opioid Treatment Programs.
Understand the impact of the Final Rule changes on patient outcomes, including retention in treatment, drug screening, and social determinants of health.

Disclosure(s):

Robert C. Sherrick, MD, DFASAM: No financial relationships to disclose

Hillary Tamar, MD, FASAM: No financial relationships to disclose

Mark Schaefer, ED.S, MA: No financial relationships to disclose